Evidence map›Paper›PMID 24858702›Full record

Trial reportPloS one2014

Filaggrin gene mutation c.3321delA is associated with various clinical features of atopic dermatitis in the Chinese Han population.

Li Meng, Li Wang, Huayang Tang, Xianfa Tang, Xiaoyun Jiang, Jinhua Zhao, Jing Gao, Bing Li, Xuhui Fu, Yan Chen and 10 more

Abstract readClinical TrialMulticenter Study
In one paragraph

Trial report in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Classifying atopic dermatitis: a systematic review of phenotypes and associated characteristics.Journal of the European Academy of Dermatology and Venereology : JEADV · 2022
    Pooled it
  3. Review
  4. Article
  5. Ichthyosis vulgaris: An updated review.Skin health and disease · 2023
    Review
  6. Review
  7. Article
  8. Skin barrier defects in atopic dermatitis: From old idea to new opportunity.Allergology international : official journal of the Japanese Society of Allergology · 2022
    Review
  9. Article
  10. Cytokines and apoptosis in atopic dermatitis.Postepy dermatologii i alergologii · 2021
    Review
  11. Filaggrin and atopic march.Biochemia medica · 2019
    Review
  12. Epithelial barrier repair and prevention of allergy.The Journal of clinical investigation · 2019
    Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Genetic and epigenetic studies of atopic dermatitis.Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology · 2016
    Review
  18. Filaggrin silencing by shRNA directly impairs the skin barrier function of normal human epidermal keratinocytes and then induces an immune response.Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologica · 2015
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Li MengInstitute of Dermatology and Department of Dermatology, No.1 Hospital, Anhui Medical University, Hefei, Anhui, China; Key Laboratory of Dermatology, Anhui Medical University, Ministry of Education, China, Hefei, Anhui, China; State Key Laboratory Incubation Base of Dermatology, Anhui Medical University, Hefei, Anhui, China.
Li WangInstitute of Dermatology and Department of Dermatology, No.1 Hospital, Anhui Medical University, Hefei, Anhui, China; Key Laboratory of Dermatology, Anhui Medical University, Ministry of Education, China, Hefei, Anhui, China; State Key Laboratory Incubation Base of Dermatology, Anhui Medical University, Hefei, Anhui, China.
Huayang TangInstitute of Dermatology and Department of Dermatology, No.1 Hospital, Anhui Medical University, Hefei, Anhui, China; Key Laboratory of Dermatology, Anhui Medical University, Ministry of Education, China, Hefei, Anhui, China; State Key Laboratory Incubation Base of Dermatology, Anhui Medical University, Hefei, Anhui, China.
Xianfa TangInstitute of Dermatology and Department of Dermatology, No.1 Hospital, Anhui Medical University, Hefei, Anhui, China; Key Laboratory of Dermatology, Anhui Medical University, Ministry of Education, China, Hefei, Anhui, China; State Key Laboratory Incubation Base of Dermatology, Anhui Medical University, Hefei, Anhui, China.
Xiaoyun JiangInstitute of Dermatology and Department of Dermatology, No.1 Hospital, Anhui Medical University, Hefei, Anhui, China; Key Laboratory of Dermatology, Anhui Medical University, Ministry of Education, China, Hefei, Anhui, China; State Key Laboratory Incubation Base of Dermatology, Anhui Medical University, Hefei, Anhui, China.
Jinhua ZhaoInstitute of Dermatology and Department of Dermatology, No.1 Hospital, Anhui Medical University, Hefei, Anhui, China; Key Laboratory of Dermatology, Anhui Medical University, Ministry of Education, China, Hefei, Anhui, China; State Key Laboratory Incubation Base of Dermatology, Anhui Medical University, Hefei, Anhui, China.
Jing GaoInstitute of Dermatology and Department of Dermatology, No.1 Hospital, Anhui Medical University, Hefei, Anhui, China; Key Laboratory of Dermatology, Anhui Medical University, Ministry of Education, China, Hefei, Anhui, China; State Key Laboratory Incubation Base of Dermatology, Anhui Medical University, Hefei, Anhui, China.
Bing LiInstitute of Dermatology and Department of Dermatology, No.1 Hospital, Anhui Medical University, Hefei, Anhui, China; Key Laboratory of Dermatology, Anhui Medical University, Ministry of Education, China, Hefei, Anhui, China; State Key Laboratory Incubation Base of Dermatology, Anhui Medical University, Hefei, Anhui, China.
Xuhui FuInstitute of Dermatology and Department of Dermatology, No.1 Hospital, Anhui Medical University, Hefei, Anhui, China; Key Laboratory of Dermatology, Anhui Medical University, Ministry of Education, China, Hefei, Anhui, China; State Key Laboratory Incubation Base of Dermatology, Anhui Medical University, Hefei, Anhui, China.
Yan ChenInstitute of Dermatology and Department of Dermatology, No.1 Hospital, Anhui Medical University, Hefei, Anhui, China; Key Laboratory of Dermatology, Anhui Medical University, Ministry of Education, China, Hefei, Anhui, China; State Key Laboratory Incubation Base of Dermatology, Anhui Medical University, Hefei, Anhui, China.
Weiyi YaoInstitute of Dermatology and Department of Dermatology, No.1 Hospital, Anhui Medical University, Hefei, Anhui, China; Key Laboratory of Dermatology, Anhui Medical University, Ministry of Education, China, Hefei, Anhui, China; State Key Laboratory Incubation Base of Dermatology, Anhui Medical University, Hefei, Anhui, China.
Wenying ZhanInstitute of Dermatology and Department of Dermatology, No.1 Hospital, Anhui Medical University, Hefei, Anhui, China; Key Laboratory of Dermatology, Anhui Medical University, Ministry of Education, China, Hefei, Anhui, China; State Key Laboratory Incubation Base of Dermatology, Anhui Medical University, Hefei, Anhui, China.
Bo WuInstitute of Dermatology and Department of Dermatology, No.1 Hospital, Anhui Medical University, Hefei, Anhui, China; Key Laboratory of Dermatology, Anhui Medical University, Ministry of Education, China, Hefei, Anhui, China; State Key Laboratory Incubation Base of Dermatology, Anhui Medical University, Hefei, Anhui, China.
Dawei DuanInstitute of Dermatology and Department of Dermatology, No.1 Hospital, Anhui Medical University, Hefei, Anhui, China; Key Laboratory of Dermatology, Anhui Medical University, Ministry of Education, China, Hefei, Anhui, China; State Key Laboratory Incubation Base of Dermatology, Anhui Medical University, Hefei, Anhui, China.
Changbing ShenInstitute of Dermatology and Department of Dermatology, No.1 Hospital, Anhui Medical University, Hefei, Anhui, China; Key Laboratory of Dermatology, Anhui Medical University, Ministry of Education, China, Hefei, Anhui, China; State Key Laboratory Incubation Base of Dermatology, Anhui Medical University, Hefei, Anhui, China.
Hui ChengInstitute of Dermatology and Department of Dermatology, No.1 Hospital, Anhui Medical University, Hefei, Anhui, China; Key Laboratory of Dermatology, Anhui Medical University, Ministry of Education, China, Hefei, Anhui, China; State Key Laboratory Incubation Base of Dermatology, Anhui Medical University, Hefei, Anhui, China.
Xianbo ZuoInstitute of Dermatology and Department of Dermatology, No.1 Hospital, Anhui Medical University, Hefei, Anhui, China; Key Laboratory of Dermatology, Anhui Medical University, Ministry of Education, China, Hefei, Anhui, China; State Key Laboratory Incubation Base of Dermatology, Anhui Medical University, Hefei, Anhui, China.
Sen YangInstitute of Dermatology and Department of Dermatology, No.1 Hospital, Anhui Medical University, Hefei, Anhui, China; Key Laboratory of Dermatology, Anhui Medical University, Ministry of Education, China, Hefei, Anhui, China; State Key Laboratory Incubation Base of Dermatology, Anhui Medical University, Hefei, Anhui, China.
Liangdan SunInstitute of Dermatology and Department of Dermatology, No.1 Hospital, Anhui Medical University, Hefei, Anhui, China; Key Laboratory of Dermatology, Anhui Medical University, Ministry of Education, China, Hefei, Anhui, China; State Key Laboratory Incubation Base of Dermatology, Anhui Medical University, Hefei, Anhui, China.
Xuejun ZhangInstitute of Dermatology and Department of Dermatology, No.1 Hospital, Anhui Medical University, Hefei, Anhui, China; Key Laboratory of Dermatology, Anhui Medical University, Ministry of Education, China, Hefei, Anhui, China; State Key Laboratory Incubation Base of Dermatology, Anhui Medical University, Hefei, Anhui, China; Department of Dermatology at No.2 Hospital, Anhui Medical University, Hefei, Anhui, China; Department of Dermatology, Huashan Hospital of Fudan University, Shanghai, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundWe confirmed that the filaggrin gene mutation c.3321delA is associated with atopic dermatitis in our previous genome wide association study of the Chinese Han population. c.3321delA is the most common filaggrin gene mutation in Chinese atopic dermatitis patients but is not present in European populations.

objectiveTo investigate the genetic model for the c.3321delA mutation and to determine the correlation between c.3321delA and atopic dermatitis clinical phenotypes in the Chinese Han population.

methodThe filaggrin gene mutation c.3321delA was sequenced in 1,080 atopic dermatitis patients and 908 controls from the Chinese population. The χ2 test, ANOVA,nonparametric tests and logistic regression were used to investigate the relationship between the c.3321delA genotype and atopic dermatitis clinical phenotypes in the Chinese Han population.

resultsAnalyses of the genetic model revealed that the additive model best described the c.3321delA mutation (P = 3.09E-11, OR = 3.43, 95%CI = 2.38-4.96). Stratified analyses showed that the c.3321delA allele frequency distribution is significantly associated with concomitant skin xerosis (P = 1.68E-03, OR = 2.13,95%CI = 1.32-3.46), palmar hyperlinearity (P = 3.64E-17, OR = 4.0,95%CI = 2.86-5.70), white dermatographism (P = 4.25E-03, OR = 1.82,95%CI = 1.22-2.71), food intolerance (P = 1.51E-03, OR = 1.76,95%CI = 1.23-2.50) and disease severity ( P = 9.67E-05).

conclusionOur study indicates that the filaggrin gene mutation c.3321delA is associated with clinical phenotypes of atopic dermatitis in the Chinese Han population, which might help us gain a better understanding on the pathogenesis of atopic dermatitis.

Indexed as

Models, GeneticMutationAdolescentAdultAsian PeopleChildChild, PreschoolChinaDermatitis, AtopicFemaleFilaggrin ProteinsHumansInfantIntermediate Filament ProteinsMaleMiddle AgedFilaggrin ProteinsFLG protein, humanIntermediate Filament Proteins

Identifiers

PMID24858702
PMCPMC4032331

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.